ACAD
35.91
-0.72
-1.97%
AEMD
7.6
+0.01
+0.13%
APRI
1.78
+0.08
+4.71%
ARNA
2.56
-0.15
-5.54%
ATEC
0.58
0.00
+0.87%
CNAT
3.73
-0.2
-5.09%
CRXM
0.35
-0.02
-5.41%
CYTX
0.38
+0.02
+4.94%
DXCM
87.82
-6.32
-6.71%
GNMK
9.66
-0.68
-6.58%
HALO
16.62
-0.84
-4.81%
ILMN
193.13
-4.48
-2.27%
INNV
0.13
-0.018
-12.2297%
INO
7.1
-0.39
-5.21%
ISCO
3.8
-0.1
-2.56%
ISIS
48.75
-1.43
-2.85%
LGND
88.48
-3.46
-3.76%
LPTN
0.25
+0.02
+8.70%
MBVX
1.8
+0.05
+2.86%
MEIP
1.8
-0.02
-1.10%
MNOV
3.05
+0.1
+3.39%
MRTX
26.57
+0.75
+2.90%
MSTX
0.48
-0.01
-1.03%
NBIX
47.05
+0.67
+1.44%
NUVA
52.01
-0.71
-1.35%
ONCS
5.77
+0.39
+7.25%
ONVO
2.45
-0.28
-10.26%
OREX
2.68
-0.09
-3.25%
OTIC
21.45
-1.22
-5.38%
QDEL
20.28
-0.31
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
8.26
-0.07
-0.84%
RMD
50.75
-1.19
-2.29%
SCIE
0.014
0.00
0.00%
SPHS
0.85
-0.05
-5.56%
SRNE
12.46
-0.22
-1.74%
TROV
5.72
-0.23
-3.87%
VICL
0.61
+0.02
+3.35%
VOLC
18
0.00
0.00%
ZGNX
18.48
-0.74
-3.85%
ACAD
35.91
-0.72
-1.97%
AEMD
7.6
+0.01
+0.13%
APRI
1.78
+0.08
+4.71%
ARNA
2.56
-0.15
-5.54%
ATEC
0.58
0.00
+0.87%
CNAT
3.73
-0.2
-5.09%
CRXM
0.35
-0.02
-5.41%
CYTX
0.38
+0.02
+4.94%
DXCM
87.82
-6.32
-6.71%
GNMK
9.66
-0.68
-6.58%
HALO
16.62
-0.84
-4.81%
ILMN
193.13
-4.48
-2.27%
INNV
0.13
-0.018
-12.2297%
INO
7.1
-0.39
-5.21%
ISCO
3.8
-0.1
-2.56%
ISIS
48.75
-1.43
-2.85%
LGND
88.48
-3.46
-3.76%
LPTN
0.25
+0.02
+8.70%
MBVX
1.8
+0.05
+2.86%
MEIP
1.8
-0.02
-1.10%
MNOV
3.05
+0.1
+3.39%
MRTX
26.57
+0.75
+2.90%
MSTX
0.48
-0.01
-1.03%
NBIX
47.05
+0.67
+1.44%
NUVA
52.01
-0.71
-1.35%
ONCS
5.77
+0.39
+7.25%
ONVO
2.45
-0.28
-10.26%
OREX
2.68
-0.09
-3.25%
OTIC
21.45
-1.22
-5.38%
QDEL
20.28
-0.31
-1.51%
RCPT
231.96
0.00
0.00%
RGLS
8.26
-0.07
-0.84%
RMD
50.75
-1.19
-2.29%
SCIE
0.014
0.00
0.00%
SPHS
0.85
-0.05
-5.56%
SRNE
12.46
-0.22
-1.74%
TROV
5.72
-0.23
-3.87%
VICL
0.61
+0.02
+3.35%
VOLC
18
0.00
0.00%
ZGNX
18.48
-0.74
-3.85%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …